Jonathan Hensman, Leo C Hahn, Mary J van Schooneveld, Roselie M H Diederen, Jacoline B Ten Brink, Ralph J Florijn, Arthur A Bergen, Ine Strubbe, Pam Heutinck, Maria M van Genderen, L Ingeborgh van den Born, Alberta A Thiadens, Julie de Zaeytijd, Bart P Leroy, Carel B Hoyng, Camiel J F Boon
PURPOSE: To date, there is no standard treatment regimen for carbonic anhydrase inhibitors (CAI) in X-linked retinoschisis (XLRS) patients. This retrospective study aims to evaluate the efficacy of CAI on visual acuity and cystoid fluid collections (CFC) in XRLS patients in Dutch and Belgian tertiary referral centers. DESIGN: Retrospective cohort study PARTICIPANTS: Forty-two patients with X-linked retinoschisis METHODS: In total, 42 patients were enrolled. To be included, patients had to have previous treatment with oral CAI (acetazolamide), topical CAI (brinzolamide/dorzolamide), or a combination of oral and topical CAI for at least 4 consecutive weeks...
December 15, 2023: Ophthalmology Retina